REFERENCES
- Patented Medicine Prices Review Board annual report 2001. Ottawa: PMPRB; 2001.
- SECOR. A coherent strategy to leverage life science R&D investments. Ottawa: SECOR; 2003.
- Jacobzone S. Pharmaceutical policies in OECD countries: Reconciling social and industrial goals. Labour Market and Social Policy Occasional Paper No. 40. Paris: Organisation for Economic Co-operation and Development; 2000.
- Campbell S. The socio-economic importance of chemistry in Europe. www.rsc.org/ lap/publicaf/pressreleases/2004/pdf/Campbell_Brussels.ppt#283,25,Competitiveness Council.
- Arlington S. Pharma 2005: An industrial revolution in R&D. Pharmaceutical Executive. 2000; 20(Jan):74–84.
- Patented Medicine Prices Review Board. A comparison of pharmaceutical re-search and development spending. S-0217. Ottawa: PMPRB; December 2002.